Fresenius Kabi
27 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Fresenius Kabi and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-06-17FDA-DrugClass IIIFresenius Kabi epinephrine injection recalled for impurity concerns
Failed Impurities/Degradations Specifications
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi dextrose injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIDo not use Fresenius Kabi dextrose injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi dextrose injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi sodium chloride injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass II0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05.
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIDo not use Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi sodium chloride injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugClass IIStop using recalled Fresenius Kabi vancomycin injection
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugClass IIStop using Fresenius Kabi vancomycin HCl IV bags
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugClass IIDo not use Fresenius Kabi thiamine HCl injection
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugClass IIDo not use Fresenius Kabi ketamine HCl injection
Lack of Assurance of Sterility
- 2026-02-18FDA-DrugClass IIDo not use Fresenius Kabi acyclovir sodium IV bags
Lack of Assurance of Sterility
- 2026-01-21FDA-DeviceClass IICheck Fresenius Kabi Ivenix Infusion System software
Emphasizing instructions for LVP duration programming located in the IFU.
- 2025-12-24FDA-DeviceClass IUpdate Ivenix Infusion System software immediately
Software version 5.10.1 and earlier contain anomalies that have the potential to cause serious patient harm or death.
- 2025-12-10FDA-DeviceClass IIIvenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004.
Downstream Occlusion alarms may occur during procedures using low flow infusion rates when a check valve* is added to the Ivenix Administration Set.
- 2025-12-10FDA-DeviceClass IIVENIX INFUSION SYSTEM, LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Dual Y-Site (Qty 25). Large Volume Infusion Pump Administration Set.
Incorrect assembly of specific lot of LVP Primary Administration Set that could result in serious patient injury.
- 2025-12-03FDA-DrugClass IFamotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
- 2025-11-05FDA-DeviceClass IIIvenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004.
Potential issue that can cause the device to register "phantom" touches in the lower-left corner of the touchscreen during operation.
- 2022-10-12FDA-DeviceClass IStop using Ivenix Infusion System version 5.2.0
The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondary notification. However, as the screen goes blank it does not indicate an alarm condition or respond. This issue leads to temporary cessation of flow of a medication or fluid, requiring immediate intervention by the clinician.
Get notified about new Fresenius Kabi recalls
Free weekly digest. We email when a new federal recall affects Fresenius Kabi or anything else in your household.
Get the Sunday Brief